Abstracts tagged "activity score and systemic sclerosis"

Abstract Number: 2992 • 2015 ACR/ARHP Annual Meeting
Identification of a New Set of Activity Criteria for Systemic Sclerosis. Preliminary Report
Gabriele Valentini¹, Michele Iudici², Veronika K. Jaeger³, Christopher P. Denton⁴, Oliver Distler⁵, Otylia M. Kowal-Bielecka⁶, Ulf Müller-Ladner⁷, Gabriela Riemekasten⁸, Ulrich A. Walker³, Suzana Jordan⁵, Elise Siegert⁸, Serena Vettori² and Yannick Allanore⁹, ¹Department of Clinical and Experimental Medicine, Rheumatology Unit, Rheumatology Unit, Second University of Naples, Naples, Italy, ²Department of Internal and Experimental Medicine, Rheumatology Unit, Second University of Naples, Naples, Italy, ³Department of Rheumatology, University Hospital Basel, Basel, Switzerland, ⁴Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, ⁵Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ⁶Department of Rheumatology and Internal Medicine, Medical University in Bialystok, Bialystok, Poland, ⁷Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, ⁸Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Berlin, Germany, ⁹Department of Rheumatology, University Paris Descartes and Cochin Hospital, Paris, France
Background/Purpose: The European Scleroderma Study Group (EScSG) Activity Index developed in 2001 has some limitations due to the procedure underlying its development and the inclusion…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.